Aurora A kinase activates YAP signaling in triple-negative breast cancer

Oncogene. 2017 Mar 2;36(9):1265-1275. doi: 10.1038/onc.2016.292. Epub 2016 Sep 5.

Abstract

The Yes-associated protein (YAP) is an effector that transduces the output of the Hippo pathway to transcriptional modulation. Considering the role of YAP in cancers, this protein has emerged as a key node in malignancy development. In this study, we determined that Aurora A kinase acts as a positive regulator for YAP-mediated transcriptional machinery. Specifically, YAP associates with Aurora A predominantly in the nucleus. Activation of Aurora A can impinge on YAP activity through direct phosphorylation. Moreover, aberrant expression of YAP and Aurora A signaling is highly correlated with triple-negative breast cancer (TNBC). We herein provide evidence to establish the functional relevance of this newly discovered regulatory axis in TNBC.

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism*
  • Animals
  • Apoptosis
  • Aurora Kinase A / metabolism*
  • Biomarkers, Tumor / metabolism*
  • Cell Proliferation*
  • Humans
  • Immunoenzyme Techniques
  • Mice
  • NIH 3T3 Cells
  • Phosphoproteins / metabolism*
  • Phosphorylation
  • Signal Transduction
  • Transcription Factors
  • Triple Negative Breast Neoplasms / metabolism*
  • Triple Negative Breast Neoplasms / pathology*
  • YAP-Signaling Proteins

Substances

  • Adaptor Proteins, Signal Transducing
  • Biomarkers, Tumor
  • Phosphoproteins
  • Transcription Factors
  • YAP-Signaling Proteins
  • YAP1 protein, human
  • Aurora Kinase A